Lexicon Pharmaceuticals, Inc. announced that Lonnel Coats has provided notice of his retirement as chief executive officer, effective July 7, 2024, his 10th anniversary with the company. The board of directors has initiated a search for a new chief executive officer which will consider both internal and external candidates.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.94 USD | +1.04% | +9.60% | +26.80% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.80% | 701M | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Lexicon Pharmaceuticals, Inc. Announces Resignation of Lonnel Coats as Chief Executive Officer, Effective from July 7, 2024